One year after WTO trade ministers agreed the Doha Declaration on TRIPS and Public Health, the US government, at the behest of giant pharmaceutical companies, continues to bully developing countries to introduce unnecessarily high standards of patent protection on medicines. This continued bilateral pressure restricts and delays the production of cheaper generic medicines, with potentially devastating consequences for millions of poor people.
How to cite this resource
Citation styles vary so we recommend you check what is appropriate for your context. You may choose to cite Oxfam resources as follows:
Author(s)/Editor(s). (Year of publication). Title and sub-title. Place of publication: name of publisher. DOI (where available). URL
Our FAQs page has some examples of this approach.